Miles D Hyman, MD | |
1018 E Main St, Franklin, NC 28734-2676 | |
(828) 369-1975 | |
(828) 369-7920 |
Full Name | Miles D Hyman |
---|---|
Gender | Male |
Speciality | Pain Medicine - Pain Medicine |
Location | 1018 E Main St, Franklin, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407860638 | NPI | - | NPPES |
891189A | Medicaid | NC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0000X | Pain Medicine - Pain Medicine | 9900258 (North Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Miles D Hyman, MD Po Box 509, Franklin, NC 28744-0509 Ph: (828) 369-1975 | Miles D Hyman, MD 1018 E Main St, Franklin, NC 28734-2676 Ph: (828) 369-1975 |
News Archive
University athletes with a recent concussion had changes in their brain structure and function even after they received medical clearance to return to play, a new study has found.
Saturday, September 26 officially has been designated as National Day of Action, in support of National Pain Awareness Month. To help promote awareness of chronic pain and how to access help, Valley Pain Specialists, an 11-member physicians group of board-certified, fellowship-trained pain medicine specialists, are launching a speaking circuit where they plan to meet with groups of patients and physicians throughout the community to raise awareness about pain, highlight the issues surrounding pain management and address the lack of access to pain care.
Vitamin D is essential for human health. Although much is known about its important role in bone metabolism and in certain areas of non-skeletal health, there are many open questions and topics of debate.
The Taiwan CDC reported a suspected SARS fever case on a return trip from Beijing was sent to hospital on the night of April 24, 2004.
Azur Pharma Limited today announced it has signed a definitive agreement with Elan Pharmaceuticals, Inc. (a subsidiary of Elan Corporation, plc) to acquire the analgesic therapy, PRIALT(R) (ziconotide intrathecal infusion).
› Verified 8 days ago